(3R)-3-amino-3-(4-bromo-2-methylphenyl)propan-1-ol, 95%, 250mg

2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-cyclopropylacetamide, 95.0%, 1g

1,3-Phenylenediboronic acid, 97.0%, 100g

8-Benzyl-2,8-diaza-spiro[4.5]decanedihydrochloride, 97.0%, 1g

3-Bromoquinolin-4-ol, 95.0%, 5g

4-(Methylsulfonyl)-3-(piperazin-1-yl)benzoic acid, 98%, 250mg

Closing caps, Gesch. front, Ø 25 mm 500 pcs

2-chloro-N-(cyclohexylmethyl)acetamide, 95.0%, 5g

Bicyclo[4.2.0]octa-1,3,5-trien-7-ylmethanol, 97.0%, 1g

2-Methoxy-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98+%, 250mg

6-(4-(Trifluoromethyl)phenyl)pyrazin-2-amine, 98%, 250mg

tert-butyl 4-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}piperidine-1-carboxylate, 97.0%, 1g

5-Chloro-6-methoxypyridin-2-amine, 10g